Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Antiviral drugs are used to treat viral infections such as human immunodeficiency virus (HIV), hepatitis, and influenza. Several investigational drugs are currently being developed for the treatment of HIV infection.
North America accounts for the majority of the market share due to the presence of major market players, advanced medical infrastructure, and increased awareness of viral diseases. The global antiviral drugs market size is expected to register a CAGR of -2.2% over the forecast period, 2020-2026.
The prevalence of viral infections such as HIV, hepatitis, respiratory syncytial virus (RSV), and influenza will drive the demand for antiviral drugs. However, increased precautions and awareness of vaccines for viral infections will limit the growth of the antiviral market.
The report details the trend, potential and market size of Antiviral Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Antiviral Drugsmarket, defines the market attractiveness level of Antiviral Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Antiviral Drugs industry, describes the types of Antiviral Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Antiviral Drugs market and the development prospects and opportunities of Antiviral Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Antiviral Drugs market in Chapter 13.
By Player:
Roche
Bristol-Myers Squibb
Gilead Sciences
Novartis
Merck
AbbVie
GlaxoSmithKline
Johnson & Johnson
By Type:
Reverse Transcriptase Inhibitors
Protease Inhibitors
Fusion Inhibitors
Immune System Modulators
By End-User:
Hepatitis Therapeutics
HIV/AIDS Therapeutics
Herpes Therapeutics
Influenza Therapeutics
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Antiviral Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Antiviral Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Antiviral Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Antiviral Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Antiviral Drugs Market Analysis and Outlook to 2022
-
7.1 Global Antiviral Drugs Consumption (2017-2022)
-
7.2 United States Antiviral Drugs Consumption (2017-2022)
-
7.3 Europe Antiviral Drugs Consumption (2017-2022)
-
7.4 China Antiviral Drugs Consumption (2017-2022)
-
7.5 Japan Antiviral Drugs Consumption (2017-2022)
-
7.6 India Antiviral Drugs Consumption (2017-2022)
-
7.7 South Korea Antiviral Drugs Consumption (2017-2022)
8 Region and Country-wise Antiviral Drugs Market Analysis and Outlook to 2028
-
8.1 Global Antiviral Drugs Consumption Forecast (2022-2028)
-
8.2 United States Antiviral Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Antiviral Drugs Consumption Forecast (2022-2028)
-
8.4 China Antiviral Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Antiviral Drugs Consumption Forecast (2022-2028)
-
8.6 India Antiviral Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Antiviral Drugs Consumption Forecast (2022-2028)
9 Global Antiviral Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Antiviral Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Reverse Transcriptase Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Protease Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Fusion Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Immune System Modulators Consumption and Growth Rate (2017-2022)
-
9.2 Global Antiviral Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hepatitis Therapeutics Consumption and Growth Rate (2017-2022)
-
9.2.2 Global HIV/AIDS Therapeutics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Herpes Therapeutics Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Influenza Therapeutics Consumption and Growth Rate (2017-2022)
10 Global Antiviral Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Antiviral Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Reverse Transcriptase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Protease Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Fusion Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Immune System Modulators Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Antiviral Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hepatitis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global HIV/AIDS Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Herpes Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Influenza Therapeutics Consumption Forecast and Growth Rate (2022-2028)
11 Global Antiviral Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Antiviral Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Antiviral Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Antiviral Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Antiviral Drugs Market Competitive Analysis
-
14.1 Roche
-
14.1.1 Roche Company Details
-
14.1.2 Roche Antiviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Roche Antiviral Drugs Product and Service
-
14.2 Bristol-Myers Squibb
-
14.2.1 Bristol-Myers Squibb Company Details
-
14.2.2 Bristol-Myers Squibb Antiviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bristol-Myers Squibb Antiviral Drugs Product and Service
-
14.3 Gilead Sciences
-
14.3.1 Gilead Sciences Company Details
-
14.3.2 Gilead Sciences Antiviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Gilead Sciences Antiviral Drugs Product and Service
-
14.4 Novartis
-
14.4.1 Novartis Company Details
-
14.4.2 Novartis Antiviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Novartis Antiviral Drugs Product and Service
-
14.5 Merck
-
14.5.1 Merck Company Details
-
14.5.2 Merck Antiviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Merck Antiviral Drugs Product and Service
-
14.6 AbbVie
-
14.6.1 AbbVie Company Details
-
14.6.2 AbbVie Antiviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 AbbVie Antiviral Drugs Product and Service
-
14.7 GlaxoSmithKline
-
14.7.1 GlaxoSmithKline Company Details
-
14.7.2 GlaxoSmithKline Antiviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 GlaxoSmithKline Antiviral Drugs Product and Service
-
14.8 Johnson & Johnson
-
14.8.1 Johnson & Johnson Company Details
-
14.8.2 Johnson & Johnson Antiviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Johnson & Johnson Antiviral Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Antiviral Drugs
-
Figure Antiviral Drugs Picture
-
Table Global Antiviral Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Antiviral Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Antiviral Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Antiviral Drugs Consumption by Country (2017-2022)
-
Figure United States Antiviral Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Antiviral Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Antiviral Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Antiviral Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Antiviral Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Antiviral Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Antiviral Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Antiviral Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Antiviral Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Antiviral Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Antiviral Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Antiviral Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Antiviral Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Reverse Transcriptase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Protease Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Fusion Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Immune System Modulators Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatitis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global HIV/AIDS Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Herpes Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Influenza Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Reverse Transcriptase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Protease Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Fusion Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immune System Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hepatitis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global HIV/AIDS Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Herpes Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Influenza Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Antiviral Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Antiviral Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Antiviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Antiviral Drugs Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Antiviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Antiviral Drugs Product and Service
-
Table Gilead Sciences (Foundation Year, Company Profile and etc.)
-
Table Gilead Sciences Antiviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Antiviral Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Antiviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Antiviral Drugs Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Antiviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Antiviral Drugs Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Antiviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Antiviral Drugs Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Antiviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Antiviral Drugs Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Antiviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Antiviral Drugs Product and Service
-
